David Zimmer
Psychiatry · Annandale, VANPI 1063686566
Payments from drug & device makers
Across 235 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$718
- Takeda Pharmaceuticals U.S.A., Inc.$612
- Lundbeck LLC$544
- Axsome Therapeutics, Inc.$488
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$481
- Alkermes, Inc.$372
- plus $2K from 12 others
What the payments were for
- Food & beverage$5,12397%
- Education$1633%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $718 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $612 |
| Lundbeck LLC | 26 | $544 |
| Axsome Therapeutics, Inc. | 21 | $488 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $481 |
| Alkermes, Inc. | 16 | $372 |
| Sunovion Pharmaceuticals Inc. | 15 | $369 |
| Johnson & Johnson | 17 | $333 |
| Otsuka America Pharmaceutical, Inc. | 14 | $307 |
| Ironshore Pharmaceuticals Inc. | 7 | $281 |
| Supernus Pharmaceuticals, Inc. | 9 | $250 |
| Jazz Pharmaceuticals Inc. | 9 | $173 |
| Corium, LLC | 8 | $145 |
| Neurocrine Biosciences, Inc. | 8 | $141 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Eisai Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,286 in reported general payments places this provider in the 90th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuvelityDextromethorphan Hbr/Bupropion | 13 | $8,101 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 59 | $3,694 |
| Lisdexamfetamine Dimesylate | 11 | $2,980 |
| Clozapine | 19 | $1,712 |
| Bupropion XlBupropion Hcl | 44 | $1,656 |
| Modafinil | 22 | $1,245 |
| Nefazodone Hcl | 12 | $1,195 |
| Mirtazapine | 29 | $1,077 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $1,040 |
| Zolpidem Tartrate ErZolpidem Tartrate | 23 | $1,026 |
| Lamotrigine | 37 | $794 |
| Lorazepam IntensolLorazepam | 16 | $735 |
| Bupropion Hcl SrBupropion Hcl | 18 | $660 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 22 | $641 |
| Fluoxetine Hcl | 27 | $561 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $488 | $8,10113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 884 psychiatry providers in Virginia.
Other psychiatry in Annandale
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
- Kent McDanielGlen Allen$2.1M
- Jasdeep MiglaniManassas$958K
- Frederick MoellerRichmond$678K
- David SpiegelNorfolk$565K
- Christopher van EyckStafford$392K
- Anita ClaytonCharlottesville$356K
- Anita KablingerRoanoke$333K
- William YetterVirginia Beach$312K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.